Thyroid C-cell Tumors: In rodent scientific studies, semaglutide has long been shown to result in thyroid C-mobile tumors. It's not known no matter if this risk applies to humans, but semaglutide is contraindicated in patients with a personal or spouse and children record of medullary thyroid carcinoma (MTC) or clients with Several Endocrine Neopla